Omni Biotech Innovations is a Canadian based, early-stage drug discovery company focused on developing differentiated antibodies to treat autoimmune diseases. Autoimmune diseases represent a large, underserved market in which current therapies still suffer from low remission rates and serious side effects. While bispecific and multispecific antibody approaches have shown promise in cancer, they remain underexplored in autoimmune disorders, presenting a unique opportunity for us.

Recognizing the unmet need, we’re developing antibody therapeutics by leveraging validated targets and innovative engineering to deliver superior efficacy and safety. With robust science, talent, and infrastructure, we are poised to deliver potentially “best-in-class” antibody treatments.